Francesca Morgese

1.3k total citations
42 papers, 830 citations indexed

About

Francesca Morgese is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Francesca Morgese has authored 42 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Francesca Morgese's work include Electrolyte and hormonal disorders (10 papers), Neuroendocrine Tumor Research Advances (8 papers) and Neuroblastoma Research and Treatments (7 papers). Francesca Morgese is often cited by papers focused on Electrolyte and hormonal disorders (10 papers), Neuroendocrine Tumor Research Advances (8 papers) and Neuroblastoma Research and Treatments (7 papers). Francesca Morgese collaborates with scholars based in Italy, United Kingdom and Germany. Francesca Morgese's co-authors include Rossana Berardi, Silvia Rinaldi, Mariangela Torniai, Stefano Cascinu, Miriam Caramanti, Agnese Savini, Azzurra Onofri, Matteo Santoni, Ilaria Fiordoliva and Riccardo Giampieri and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of Oncology.

In The Last Decade

Francesca Morgese

41 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Morgese Italy 19 370 335 186 127 104 42 830
Azzurra Onofri Italy 15 382 1.0× 376 1.1× 193 1.0× 75 0.6× 113 1.1× 39 838
Mariangela Torniai Italy 17 336 0.9× 296 0.9× 122 0.7× 138 1.1× 90 0.9× 43 694
Agnese Savini Italy 15 299 0.8× 323 1.0× 166 0.9× 82 0.6× 99 1.0× 35 689
Diana Flores‐Estrada Mexico 16 284 0.8× 477 1.4× 143 0.8× 124 1.0× 119 1.1× 41 1.0k
F. Gómez France 13 411 1.1× 322 1.0× 236 1.3× 164 1.3× 174 1.7× 30 1.0k
R. Morant Switzerland 22 494 1.3× 722 2.2× 243 1.3× 78 0.6× 185 1.8× 54 1.3k
Ping‐Ping Bao China 22 292 0.8× 604 1.8× 400 2.2× 90 0.7× 113 1.1× 71 1.3k
Manabu Yamamoto Japan 19 456 1.2× 417 1.2× 212 1.1× 63 0.5× 422 4.1× 109 1.2k
Nuri Karadurmuş Türkiye 16 171 0.5× 236 0.7× 112 0.6× 129 1.0× 98 0.9× 112 712
Tao Jin China 18 289 0.8× 288 0.9× 203 1.1× 127 1.0× 271 2.6× 73 1.0k

Countries citing papers authored by Francesca Morgese

Since Specialization
Citations

This map shows the geographic impact of Francesca Morgese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Morgese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Morgese more than expected).

Fields of papers citing papers by Francesca Morgese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Morgese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Morgese. The network helps show where Francesca Morgese may publish in the future.

Co-authorship network of co-authors of Francesca Morgese

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Morgese. A scholar is included among the top collaborators of Francesca Morgese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Morgese. Francesca Morgese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morgese, Francesca, et al.. (2023). Potential dual synergy between electrochemotherapy and sequence of immunotherapies in metastatic melanoma: A case report. Molecular and Clinical Oncology. 18(2). 8–8. 3 indexed citations
2.
Maccaroni, Elena, Veronica Agostinelli, Riccardo Giampieri, et al.. (2021). Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type. SHILAP Revista de lepidopterología. 2(3). 240–248. 3 indexed citations
3.
Berardi, Rossana, Francesca Morgese, Silvia Rinaldi, et al.. (2020). Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management. SHILAP Revista de lepidopterología. 1 indexed citations
4.
Mentrasti, Giulia, Mariangela Torniai, Riccardo Giampieri, et al.. (2020). Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management. SHILAP Revista de lepidopterología. 1 indexed citations
5.
Berardi, Rossana, Gaia Goteri, Vittorio Paolucci, et al.. (2020). The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions. Journal of Thoracic Disease. 12(12). 7245–7256. 2 indexed citations
6.
Berardi, Rossana, Federico Mocchegiani, Silvia Rinaldi, et al.. (2020). Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study. SHILAP Revista de lepidopterología. 8(1). 115–124. 4 indexed citations
7.
Berardi, Rossana, Francesca Morgese, Silvia Rinaldi, et al.. (2020). <p>Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management</p>. Cancer Management and Research. Volume 12. 9363–9374. 74 indexed citations
8.
Cantini, Luca, Filippo Merloni, Silvia Rinaldi, et al.. (2020). Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 151. 102974–102974. 20 indexed citations
9.
Mentrasti, Giulia, Mariangela Torniai, Riccardo Giampieri, et al.. (2020). <p>Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management</p>. Therapeutics and Clinical Risk Management. Volume 16. 663–672. 23 indexed citations
10.
Cantini, Luca, Federica Pecci, Marco Tomasetti, et al.. (2020). Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis. Lung Cancer. 146. 318–326. 13 indexed citations
11.
Rinaldi, Silvia, Francesca Morgese, Mariangela Torniai, et al.. (2016). Gemcitabine as single agent second line treatment in patients with advanced wild-type EGFR, negative ALK non-small cell lung cancer: a retrospective study. Annals of Oncology. 27. iv15–iv15.
12.
Berardi, Rossana, Ilaria Fiordoliva, M. De Lisa, et al.. (2016). Clinical and Pathologic Predictors of Clinical Outcome of Malignant Pleural Mesothelioma. Tumori Journal. 102(2). 190–195. 8 indexed citations
13.
Berardi, Rossana, Silvia Rinaldi, Miriam Caramanti, et al.. (2016). Hyponatremia in cancer patients: Time for a new approach. Critical Reviews in Oncology/Hematology. 102. 15–25. 49 indexed citations
14.
Berardi, Rossana, Matteo Santoni, Silvia Rinaldi, et al.. (2016). Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials. PLoS ONE. 11(5). e0152079–e0152079. 39 indexed citations
15.
Berardi, Rossana, Miriam Caramanti, Simona Guglielmi, et al.. (2015). Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. Supportive Care in Cancer. 23(10). 3095–3101. 49 indexed citations
16.
Berardi, Rossana, Silvia Rinaldi, Mariangela Torniai, et al.. (2015). Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy—A literature review. Critical Reviews in Oncology/Hematology. 98. 264–274. 24 indexed citations
17.
Berardi, Rossana, Gianluca Valeri, Mirco Pistelli, et al.. (2014). Chromium Exposure and Germinal Embryonal Carcinoma: First Two Cases and Review of the Literature. Journal of Toxicology and Environmental Health. 78(1). 1–6. 18 indexed citations
18.
Berardi, Rossana, Matteo Santoni, Francesca Morgese, et al.. (2013). Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer. OncoTargets and Therapy. 6. 563–563. 20 indexed citations
19.
Berardi, Rossana, M. De Lisa, Azzurra Onofri, et al.. (2013). Thymic neoplasms: An update on the use of chemotherapy and new targeted therapies. A literature review. Cancer Treatment Reviews. 40(4). 495–506. 11 indexed citations
20.
Berardi, Rossana, Federico Mocchegiani, Chiara Pierantoni, et al.. (2012). Resected biliary tract cancers: A novel clinical–pathological score correlates with global outcome. Digestive and Liver Disease. 45(1). 70–74. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Azzurra Onofri Breakdown of academic impact, for papers by Mariangela Torniai Breakdown of academic impact, for papers by Agnese Savini Breakdown of academic impact, for papers by Diana Flores‐Estrada Breakdown of academic impact, for papers by F. Gómez Breakdown of academic impact, for papers by R. Morant Breakdown of academic impact, for papers by Ping‐Ping Bao Breakdown of academic impact, for papers by Manabu Yamamoto Breakdown of academic impact, for papers by Nuri Karadurmuş Breakdown of academic impact, for papers by Tao Jin
Rankless by CCL
2026